Work for Celldex Therapeutics Inc.?

Claim Your Profile

Celldex Therapeutics Inc. Logo Image

Celldex Therapeutics Inc.

Celldex Therapeutics Inc. Banner Image

Most Recent Annual Report

2015 Form 10K

Celldex Therapeutics Inc.

Annual
Report

Order Free Hardcopy

You can request a free hardcopy of this report mailed to you by clicking the button below.

Add Annual Report

About Celldex Therapeutics Inc.

51-200 Employees
Based in Hampton, New Jersey

Celldex Therapeutics is the first antibody-based combination immunotherapy company. Celldex has a pipeline of drug candidates in development for the treatment of cancer and other difficult-to-treat diseases based on its antibody focused Precision Targeted Immunotherapy Platform. The PTI Platform is a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators used in optimal combinations to create novel disease-specific drug candidates.

Ticker:
CLDX
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Diagnostic Substances (See More Diagnostic Substances Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?